Skip to content

Innovations in HIV Testing

Innovations in HIV Testing to Enhance Care for Young Women and Their Peers and Partners

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03162965
Acronym
TI
Enrollment
898
Registered
2017-05-22
Start date
2016-12-01
Completion date
2018-10-31
Last updated
2019-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Immunodeficiency Virus

Brief summary

The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facilitating linkage to care.

Detailed description

The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facilitating linkage to care. In this study the investigators proposed two phases. The first phase, previously completed, is formative and involved two parts: 1) conducting formative qualitative research to understand perceptions of HIV testing and HIV self-testing in the study population and 2) conducting observed HIV self-testing to better understand any challenges with self-testing and the materials needed to make the process clear. The second phase of the study is a randomized controlled trial where the investigators will randomize approximately 400 young women to receive either 1) CHOICE of self-testing or clinic-based HIV Counseling and Testing (HCT) or 2) clinic based HCT. Once young women have been randomized, they will be asked to recruit up to 4 peers or male sex partners to test with the method of their randomization group.

Interventions

OTHEROraquick HIV Self Test

This is an oral swab in home HIV test.

OTHERClinic Based HIV Counseling and Testing (HCT)

Receiving Counseling and Testing for HIV at the clinic.

Sponsors

University of Witwatersrand, South Africa
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Participants randomized to (1) Choice - they get to choose (1a) self-test vs (1b) HCT (HIV testing and counseling at clinic) or (2) they are randomized to HCT.

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

Eligibility Inclusion Criteria Index: * Females ages 18-26 * Have had sex in the past 3 months and plan to have sex again in the next 3 months * Planning on staying in the Agincourt Health and Demographic Surveillance System (AHDSS) area for the next nine months * Able and willing to provide informed consent * Willing to comply with study procedures * Not known to be HIV positive (not reporting a previous positive test) Eligibility Inclusion Criteria Peer/Partner: * Females and Males ages 18 and older * Able and willing to provide informed consent * Willing to comply with study procedures

Design outcomes

Primary

MeasureTime frameDescription
Proportion of index reporting testing uptake3 months post randomizationCompare between the two study arms the proportion of testing uptake at 3 months post-randomization. Testing uptake is defined for HCT as self-report of going to the clinic and testing; and for self-test as self-report of using a self-test kit.

Secondary

MeasureTime frameDescription
Proportion of peer/partner referrals by the index12 months post randomizationCompare between the two studies arms the number of self test kits and HCT cards distributed by the index.
Proportion of peer/partners reporting testing uptake12 months post randomizationCompare between the two study arms the proportion of testing uptake by peers/partners. Testing uptake is defined for HCT as self-report of going to the clinic and testing; and for self-test as self-report of using a self-test kit.
Proportion of index and peer/partners who obtain a confirmatory test, start Antiretroviral Treatment (ART) if HIV+, and obtain their Cluster of Differentiation 4 (CD4) count if HIV+12 months post randomizationAmong participants who test positive (young women, peers and sex partners), the investigators will examine uptake of linkage to care.

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026